| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3849040 | American Journal of Kidney Diseases | 2011 | 8 Pages |
Abstract
Despite current ESA therapy, decreased RBC survival contributes to chronic kidney disease-related anemia, although the reduction is less than previously reported. There does not appear to be net mechanical damage associated with HD therapy resulting in decreased RBC life span.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Frederiek E. MD, John B. MBChB, FRACP, Carolyn V. PhD, Terrence C.A. MBChB, MD, FRACR, Stephen B. PhD, Robert J. MBChB, MD, FRACP,